Our portfolio of products covers a broad range of therapeutic areas. For additional information about our products, please refer to the list below.

AxidAxid™ is a trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.
pdp-Amantadine
Bi-PegLyte®Bi-PegLyte® is a registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.
Patient information
  • You should have been given specific instructions about when to take Bi-PegLyte® by your doctor or nurse. Please review these instructions ahead of time. Your treatment with Bi-PegLyte® must be completed before your clinical procedure.
  • Follow the directions for use as per document attached or as directed by your healthcare professional. Contact your doctor or pharmacist if you have any questions about the drug.
  • Refrigerate the solution as chilling improves the taste. Using a straw may help the solution taste better and easier to drink.
  • Storage: Store the contents of the Bi-PegLyte® carton at room temperature (15-30°C). The freshly-reconstituted PEG/Electrolyte solution should be used within 48 hours if stored at room temperature. Discard unused portion. Keep out of reach and sight of children.
  • This product may not be right for you. Always read and follow the label.
Cingal®Cingal® is a registered trademark owned by Anika Therapeutics, Inc.. used under license by Pendopharm, a division of Pharmascience Inc.
Patient Information

Learn more about Cingal® – This site is intended for an audience in Canada

CoLyteColyte™ is a trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.
Patient information
  • You should have been given specific instructions about when to take Colyte™ by your doctor or nurse. Please review these instructions ahead of time. Your treatment with Colyte™ must be completed before your clinical procedure.
  • Follow the directions for use as per document attached or as directed by your healthcare professional. Contact your doctor or pharmacist if you have any questions about the drug.
  • Keep refrigerated during treatment, for optimal storage and to improve the taste.
  • Storage: Store the powder at room temperature (between 15 and 30°C). Keep out of reach of children. Once reconstituted, the solution should be used within 48 hours after mixing if stored at room temperature. If kept refrigerated (between 2° and 8°C), use within 30 days. Discard unused portion.
  • This product may not be right for you. Always read and follow the label.
Pdp-Desonide
Eleview®Eleview® is a registered trademark owned by Cosmo Technolgies Ltd used under license by Pendopharm, a division of Pharmascience Inc.
Entocort®Entocort® is a registered trademark owned by Tillotts Pharma AG used under license by Pendopharm, a division of Pharmascience Inc.
Entocort®Entocort® is a registered trademark owned by Tillotts Pharma AG used under license by Pendopharm, a division of Pharmascience Inc. Enema
pdp-Erythromycin
Glatect®GLATECT® is a registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.
Patient information

Learn more about Glatect®GLATECT®, GLATECT and design, and the ALLY Patient Support Program and design are registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc. and ALLY Patient Support Program

Ibavyr®Ibavyr® is a registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.
Instillagel®Instillagel® is a registered trademark owned by Farco-Pharma G.m.b.H. used under license by Pendopharm, a division of Pharmascience Inc.
Jelido®Jelido® is a registered trademark owned by Farco-Pharma G.m.b.H. used under license by Pendopharm, a division of Pharmascience Inc.
KleanLyteKleanlyte™ is a trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.
Patient Information
  • You should have been given specific instructions about when to take KleanLyte™ by your doctor or nurse. Please review these instructions ahead of time. Your treatment with KleanLyte™ must be completed before your clinical procedure.
  • Follow the directions for use as per document attached or as directed by your healthcare professional. Contact your doctor or pharmacist if you have any questions about the drug.Ensure that you hydrate adequately before, during, and after taking this product.
  • Storage: Store unopened bottles at room temperature 15 °C–30 °C. Do not use if inner seal of bottle is broken or missing. Keep out of sight and reach of children.
  • This product may not be right for you. Always read and follow the directions for use.
pdp-levETIRAcetam
Monovisc®Monovisc® is a registered trademark owned by Anika Therapeutics, Inc.. used under license by Pendopharm, a division of Pharmascience Inc.
Patient Information

Learn more about Monovisc – This site is intended for an audience in Canada

MyinflaMyinfla™ is a trademark of Pharmascience Inc.
Orthovisc®Orthovisc® is a registered trademark owned by Anika Therapeutics Inc. used under license by Pendopharm, a division of Pharmascience Inc.
Patient Information

Learn more about Orthovisc – This site is intended for an audience in Canada

Perichlor®Perichlor® is a registered trademark of Pharmascience Inc. & Perichlor®Perichlor® is a registered trademark of Pharmascience Inc. Without Alcohol
Periostat™
PegLyte®PegLyte® is a registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.
Patient Information
  • You should have been given specific instructions about when to take PegLyte® by your doctor or nurse. Please review these instructions ahead of time. Your treatment with PegLyte® must be completed before your clinical procedure.
  • Follow the directions for use as per document attached or as directed by your healthcare professional. Contact your doctor or pharmacist if you have any questions about the drug.
  • Keep refrigerated during treatment, for optimal storage and to improve the taste. Using a straw can help to make the solution taste better and easier to drink.
  • Storage: Store the powder at room temperature (between 15 and 30°C). Keep out of reach and sight of children. Once reconstituted, the solution should be used within 48 hours after mixing if stored at room temperature. If kept refrigerated (between 2- 8°C), use within 30 days. Discard unused portion.
  • This product may not be right for you. Always read and follow the label.
Pharixia®Pharixia® is a registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc & Pharixia®Pharixia® is a registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc Alcohol Free
pdp-Pyrazinamide
Solystat®Solystat® is a registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.
SportVisSportVis™ is a trademark owned by MDT Int’l SA. used under license by Pendopharm, a division of Pharmascience Inc.
Patient Information

Learn More about SportVis – This site is intended for an audience in Canada

Toloxin®Toloxin® is a registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.
Xylac®Xylac® is a registered trademark owned by Finchley Research & Development Inc. used under license by Pendopharm, a division of Pharmascience Inc.